FDA Drug Application (205921) for NEVIRAPINE by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number205921
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage400MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameNEVIRAPINE
Active IngredientNEVIRAPINE



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.